Adverse Events Associated with COVID-19 Pharmaceutical Treatments

Adverse Events Associated with COVID-19 Pharmaceutical Treatments: The purpose of the Rapid Review is to provide an overview of the risk, severity, and timing of adverse events associated with treatments for COVID-19 approved under Emergency Use Authorization or previously approved by the Food & Drug Administration (FDA). The project’s sponsor, the federal Health Resources & Services Administration (HRSA) will use the report to inform a countermeasure injury table and relevant amendments by identifying potential injuries and grading the strength of evidence between these interventions and potential injuries; once a table and any relevant amendments are published, it will be used to make decisions in compensating individuals for covered injuries or deaths. https://effectivehealthcare.ahrq.gov/